Scientifi c Article |Leuconostoc spp Sepsis in an Extremely Low Birth WeightInfant: A Case Report and Review of the LiteraturePanitan Yossuck, MDWVU School of MedicineDept. of Pediatrics, MorgantownPatricia Miller-Canfield, MDWVU School of MedicineDept. of Pathology, MorgantownKathryn Moffett, MDWVU School of MedicineDept. of Pediatrics, MorgantownJanet Graeber, MDWVU School of MedicineDept. of Pediatrics, MorgantownAbstractA three week old extremely low birthweight (ELBW) infant infected byvancomycin-resistant Leuconostoc spp ispresented. Treatment with appropriateantibiotics was successful after thepercutaneous inserted central catheter(PICC) was removed. The infection withLeuconostoc spp is rare but should besuspected when vancomycin-resistantorganisms resembling streptococci areisolated. Previous pediatric case reportsare also summarized and reviewed.IntroductionLeuconostoc spp are gram-positivecocci known to be present in plant,milk, dairy products and wine (1).It was not until the 1980s that theseorganisms were noted to haveassociation with human and animaldiseases. In 1984, Coleman and Ballreported the isolation of Leuconostocspp from blood cultures (2). In 1985,Buu-Hui et al recognized the invitro resistance of this pathogento vancomycin (3). Sporadic casereports of these organisms causingserious and sometimes fatal diseasein all patient age groups have beenpreviously reviewed by Capatepis etal in 1994 (4) and by Dhodapkar etal in 1996 (5). There were nine morepediatric case (≤ 18 yr) reports inEnglish literature since the review byDhodapkar et al in 1996 (6-12). Wereport an extremely low birth infantwith Leuconostoc bacteremia andreview the case reports caused by thisorganism in the pediatric population.Case ReportThis baby boy was bornprecipitously at 24 4/7 weekgestational age (GA) with birthweight of 700 gm to a 23 year oldmother with a history of smoking.The baby was transferred to ourunit immediately after birth. He wasnoted to have a right pneumothoraxand had chest tube placement for10 days. Initially he was placed onampicillin and gentamicin for 48hour Antibiotics were discontinuedafter negative cultures werereported. Cranial ultrasound showedbilateral grade III intraventricularhemorrhage (IVH). At one weekof age, due to increased ventilatorsupport, metabolic acidosis andincreased white blood cell count, asecond set of blood cultures weresent and the baby was started onvancomycin and gentamicin. Bothantibiotics were again discontinuedafter 48 hours since no organism wasidentified from the blood cultures. Anumbilical catheter (UAC) was initiallyplaced and then was replaced by apercutaneous inserted central catheter(PICC) when the baby was two weeksold. Trophic feeding was startedat day of life 6 and was graduallyincreased. At age 22 days, whilethe baby was still on the ventilatorwith a low FiO2 requirement andreceiving more than half of his caloricintake from enteral feeds, a routineCBC was noted to have WBC of28,000 cell per mm3, I:T ratio of 0.35,and platelet count of 37,000. Bloodcultures from two different siteswere drawn. Lumbar puncture wasperformed after platelet transfusion.The baby was started on vancomycinand gentamicin. A total of twodoses of platelet concentrate wereadministered. Within 24 hours, bloodcultures identified gram-positivecocci which were preliminarilyreported as alpha Streptococci spp.After 48 hours on vancomycin andgentamicin, the repeat blood culturesfrom two different sites were drawn.The initial blood culture was finallyreported as Leuconostoc spp andcoagulase negative Staphylococci(CONS). Ampicillin was addedto the regimen. The second set ofblood cultures continued to growboth organisms. The third set ofblood cultures 48 hours after addingampicillin were drawn whichrevealed both organisms had grown.The PICC was pulled. Another setof blood cultures were drawn at 72hours after PICC was discontinued.This time no organism was identified.The baby completed a two weekcourse of ampicillin, vancomycinand gentamicin. Cerebrospinal fluidprofiles were with in normal limit forage. Nothing grew from the CSF. Atday of life 46, three weeks after theLeuconostoc and CONS bacteremia,the baby developed frequent stools.He was NPO for 24 hour Stool C.difficile toxin test was positive. Notreatment was given since the babyspontaneously resolved and he wasback on full feeding within twodays. No necrotizing enterocolitis(NEC) was noted for the entirecourse of his hospitalization. Hewas discharged home at day 103.DiscussionLeuconostoc spp was thought tobe non-pathogenic to humans untilthe 1980s (3). These gram-positiveorganisms are normally isolated fromsoils, plant materials, dairy productsand wines (13). Although they arenot part of the usual normal flora,Leuconostoc spp have been isolatedfrom vaginal and stools samples (14).The incidence of colonization mayhave changed since the wide spread24 <strong>West</strong> <strong>Virginia</strong> <strong>Medical</strong> Journal
| Scientifi c Articleuse of vancomycin in clinical practice.Although infections secondary toLeuconostoc spp are uncommon,there have been sporadic casereports of Leuconostoc spp humaninfection in both pediatric andadult patients (4,5). Most of thesepatients had underlying diseases.In the English literature reviewedby Dhodapkar et al in 1996 (5),there were 29 cases of Leuconostocspp infection. Sixty percent of thecase reports were children. Fiveout of 18 pediatric cases werepremature infants. Since the reviewin 1996, there have been at least ninepediatric case reports. Eight are inEnglish literature. One of these wasa healthy infant. To our knowledge,this presenting case is the youngestand smallest infant that sufferedwith Leuconostoc spp infection.We reviewed 28 cases of pediatricpatient infected with Leuconostocspp from the English literature.Only three cases did not have anunderlying disease. One was a16 year old who presented witha classical manifestation of acutemeningitis (15). The second case wasa 9 month old infant who presentedwith right-side pneumonia (16).The third case was a 2.5 month oldinfant who presented with acutebronchiolitis and concomitantRSV infection (7). There was onecase where the infection occurredin a normal term newborn infantconcomitant with CONS. The infantdid not show any clinical symptomsor signs and was sent home withoutany treatment (16). Eleven out of28 cases (39%) had gastrointestinalabnormalities as an underlyingdisease. Short gut syndrome wasthe majority of these cases. Five casereports, including our case, wereborn prematurely. In the report byHardy (17) the infant was 26 weekGA when she was born. The infectionoccurred at 34 week corrected age.Two cases reported by Gollege (18)occurred in a 28 week-old and 32week-old infant. The corrected ageand the time that the infectionsoccur were not specified. The casereport by Carapetis (4) discussedan infant born at 28 week GA butLeuconostoc spp infection occurredat 20 months of age. In our case, thebaby was born at 24 6/7 week GA.The infection occurred when he was28 week corrected. Besides prematureinfants, the other major categoriesof pediatric patients infected withLeuconostoc spp were those who hadobvious immunosuppressive statessuch as leukemia and the humanimmunodeficiency virus (HIV)infection. Central venous catheter isalso a major risk factor to Leuconostocspp infection. Half of these patientshad central venous catheter inplace when the infection occurred.Exposure to vancomycin was foundin 64% of all pediatric case reports.The source of Leuconostoc sppinfections is still controversial. SomeHELPING WEST VIRGINIA PHYSICIANS TAKE THE RIGHT PATH……in litigation, privacy and security compliance, certificate of need, medical staff and professionaldisciplinary matters, credentialing concerns, complex regulatory matters and business transactions.HEALTH CARE PRACTICE GROUPRyan A. BrownRobert L. CoffieldAlaina N. CrislipJ. Dustin DillardSam FoxMichele GrinbergJohn D. HoffmanAmy R. HumphreysCharlestonJustin D. JackRichard D. JonesEdward C. MartinMark A. RobinsonAmy L. RothmanDon R. Sensabaugh, Jr.Salem C. SmithMorgantownStephen R. BrooksStacie D. HonakerWheelingDavid S. GivensPhillip T. GlyptisRobert C. JamesEdward C. Martin, Responsible Attorney | tedm@fsblaw.com | www.fsblaw.com | (304) 345-0200 | (800) 416-3225<strong>September</strong>/<strong>October</strong> 2009 | Vol. 105 25